Medable, Inc

New capabilities. New measures. New possibilities. The next era has arrived 📲 💻! This is progress… This is Medable 📈! ________ Alison Holland, Michelle Longmire, Tim Smith, Andrew Mackinnon, Colin Weller, Pamela Tenaerts, MD, MBA, Cindy Howry, MS, Hady Khoury, Amar Jani, Marc Ginsky, Martin Cook, Deanna Coscia, Tyler Pugsley #clinicaltrials #clinicalresearch #healthcare #digitalhealth

"The collaboration between Medable, Inc and Google Cloud will enable scaled and seamless adoption of digital trial solutions by Google Cloud users, providing life sciences companies with platform capabilities proven to improve patient access to trials and accelerate critical development efforts, globally.” - Dr. Michelle Longmire. Team Medable was honored to be part of Google's inaugural Cancer AI Symposium today to discuss building the trials of the future with powerful GenAI solutions. ________ Tyler Pugsley, Jeff Parker, R.J. Lozano, Deanna Coscia, Dave Orrico #clinicalresearch #clinicaltrials #AI #healthcare

Medable, Inc joins forces with Google Cloud to bring Medable’s Digital and Decentralized Clinical Trial Platform to Google Cloud Marketplace. Customers will benefit from cutting-edge Google Cloud infrastructure and AI capabilities, seamlessly integrated with Medable’s platform, including the newly launched Studio, a unique SaaS solution that provides pharmaceutical companies control and transparency in clinical trial design, deployment, and management. This strategic collaboration allows life sciences companies to accelerate clinical development while leveraging infrastructure and financial benefits. Learn more: https://lnkd.in/e9beZnMd ________ Dai Vu, Andrea McGonigle Michelle Longmire, Tim Smith, Alison Holland, Amar Jani, Marc Ginsky, Andrew Mackinnon, Pamela Tenaerts, MD, MBA, Steve Jones, Dave Orrico, Nora Volger #clinicaltrials #clinicalresearch #healthcare #googlecloud #AI

Got 2.5 minutes? That’s all you need to see how Medable Studio can transform your study launch process. Watch the demo below and unlock a new era of control, transparency, and simplicity 💻 📈! Want to see more? Contact this account directly via LinkedIn Messenger and we'll be in touch to arrange your tailored Studio experience 📥. ________ Michelle Longmire, Tim Smith, Alison Holland, Andrew Mackinnon, Tyler Pugsley, Deanna Coscia, Martin Cook #clinicaltrials #clinicalresearch #healthcare #digitalhealth

AI is poised to transform oncology clinical trials by analyzing vast, unstructured data, streamlining processes, enhancing patient engagement, and creating more diverse study cohorts. Moreover, GenAI is accelerating trial deployment through real-time digitalization of protocols and data collection. This Wednesday at Google's Inaugural Cancer AI Symposium, Join Medable, Inc CEO Dr. Michelle Longmire as she shares the latest predictions and use cases of GenAI in clinical trials. Register for the event here: https://lnkd.in/eQT5hiGu __________ #clinicaltrials #clinicalresearch #healthcare #AI

The challenges posed by disparate data systems are significant, but they're not insurmountable. Clinical trial platforms offer an easy enterprise-wide solution, providing centralized data integration, standardization, advanced analytics, and robust security features 📲💻. Learn more here: https://lnkd.in/edZgHUgG ________ #clinicaltrials #clinicalresearch #healthcare #SaaS #digitalhealth

As clinical trials continue their focus on rarer diseases and disease subtypes, biospecimen storage and their consent will remain critical to clinical research. Organizations should strongly consider eConsent technology, like Total Consent, to avoid a potential nightmare scenario. Read more below to learn how to unlock the full potential of biospecimen research while maintaining the highest standards of regulatory compliance and ethical conduct. ⬇️⬇️ ________ #clinicaltrials #clinicalresearch #econsent #biospecimens #healthcare

With BBC Research forecasting that “the global smartphone-based patient monitoring market should reach $21.5 billion by 2027,” it’s safe to say that smartphones, tablets, and other devices have become a cornerstone of modern clinical trials. Medable’s device delivery is part of our top-tier professional services function, which has already surpassed previous industry standards with a 99% on-time device shipment rate, where the remaining 1% results from normal business operation limitations such as weather outages. To expand upon this strong foundation, we’re excited to announce that David Geismar has joined Medable, Inc as EVP of Professional Services to drive widespread adoption of our world-class partner programs. David joins the team with 18 years of experience in life sciences services—having built customer enablement programs from inception to mass application. He is deeply dedicated to our vision to dramatically improve the speed, scale, and access of clinical research through technology and draws inspiration from our mission to get effective therapies to patients faster. In his new role at Medable, David will elevate our services SaaS model, including solution architecture, project management, data services, and quality engineering, while expanding our global presence into new regions. The end result? Unlocking the full potential of the Medable platform for our customers, stakeholders, and patients. ________ #clinicaltrials #clinicalresearch #healthcare #professionalservices

Next week, join us at Google's Inaugural Cancer AI Symposium and discover the new digital trial capabilities that are revolutionizing oncology 🧬. Connect with our team to explore how automation and AI can streamline trial processes, enhance patient engagement, and accelerate study deployment—all while maintaining a human touch in healthcare 👫📲. Schedule time with our team here: https://lnkd.in/dKNyWxz3 ________ Attending team members: Michelle Longmire, Tyler Pugsley, Dave Orrico, Deanna Coscia #clinicaltrials #clinicalresearch #healthcare #cancerresearch #AI

Everest Group named Medable top Trailblazer in their inaugural “Clinical Trial Patient Engagement Products Assessment.” Medable was selected out of 44 organizations and was the only company to receive a perfect score in all categories for its holistic focus on patient engagement in clinical trials. This reflects the impact of Medable's Patient Caregiver Network (PCN) – the industry’s first, largest, and most diverse patient advocacy ecosystem and cornerstone to Medable R&D. Learn more: https://lnkd.in/dfhefngd ________ Michelle Longmire, Tim Smith, Jena Daniels, Pamela Tenaerts, MD, MBA, Alison Holland, Andrew Mackinnon, Steve Jones #clinicaltrials #clinicalresearch #patientexperience #healthcare